These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3757472)

  • 1. [Determination of plasma levels of drugs: clinical perspectives and technical problems].
    Paoletti V; Mammarella A
    Clin Ter; 1986 Sep; 118(5):361-3. PubMed ID: 3757472
    [No Abstract]   [Full Text] [Related]  

  • 2. Semiquantitative measurement of drugs in urine samples and measurement of pharmaceutical active substances in serum samples using the Beckman Coulter Synchron LX20 PRO clinical system.
    König H; Lestin HG; Brinkmann T; Augsten M; Kotira B
    Clin Lab; 2007; 53(1-2):11-6. PubMed ID: 17323820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
    Denniff P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line pretreatment using methylcellulose-immobilized cation-exchange restricted access media for direct liquid chromatography/mass spectrometric determination of basic drugs in plasma.
    Kawano S; Takahashi M; Hine T; Yamamoto E; Asakawa N
    Rapid Commun Mass Spectrom; 2005; 19(19):2827-32. PubMed ID: 16144027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities and limits of toxicologic analysis in the concept of treatment].
    Müller RK; Möschwitzer G; Demme U; König H
    Z Arztl Fortbild (Jena); 1989; 83(13):686-8. PubMed ID: 2781832
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring of drug levels in blood: a challenge to the clinical biochemistry laboratory.
    Ford HC; Jellett LB; Maling TJ; Kappatos DC
    N Z Med J; 1980 May; 91(659):347-9. PubMed ID: 6930024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum levels of drugs: a valuable therapeutic tool or an expensive academic game?].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1982 Sep; 126(39):1784-6. PubMed ID: 7144941
    [No Abstract]   [Full Text] [Related]  

  • 8. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
    Spooner N; Lad R; Barfield M
    Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The present status of blood level measurements of drugs in central clinical laboratories of university and college hospitals in Japan].
    Miura Y; Abe K
    Rinsho Byori; 1985 Jul; 33(7):747-60. PubMed ID: 3906185
    [No Abstract]   [Full Text] [Related]  

  • 10. A toxicological perspective on the use of spin column extraction to detect drugs and metabolites in biological matrices.
    Namera A; Saito T
    Bioanalysis; 2012 Sep; 4(17):2087-90. PubMed ID: 23013387
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of drug analysis].
    Penttilä O
    Duodecim; 1980; 96(5):347-51. PubMed ID: 7449679
    [No Abstract]   [Full Text] [Related]  

  • 12. [The practical value of determination of plasma levels of drugs].
    Valiente R; Flórez J
    Rev Med Univ Navarra; 1988; 32(1):21-8. PubMed ID: 3154928
    [No Abstract]   [Full Text] [Related]  

  • 13. DBS: a UK (MHRA) regulatory perspective.
    Beharry M
    Bioanalysis; 2010 Aug; 2(8):1363-4. PubMed ID: 21083336
    [No Abstract]   [Full Text] [Related]  

  • 14. [Network-plan technic applied to chemical analysis].
    Dadisch GL; Machata G
    Beitr Gerichtl Med; 1978; 36():17-22. PubMed ID: 718607
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rapid determination of the free plasma fraction of drugs].
    Jadot G; Bruguerolle B; Valli M; Bouyard P
    Ann Biol Clin (Paris); 1980; 38(6):379-80. PubMed ID: 7212395
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis.
    Bruce SJ; Jonsson P; Antti H; Cloarec O; Trygg J; Marklund SL; Moritz T
    Anal Biochem; 2008 Jan; 372(2):237-49. PubMed ID: 17964273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method development aspects for the quantitation of pharmaceutical compounds in human plasma with a matrix-assisted laser desorption/ionization source in the multiple reaction monitoring mode.
    Kovarik P; Grivet C; Bourgogne E; Hopfgartner G
    Rapid Commun Mass Spectrom; 2007; 21(6):911-9. PubMed ID: 17295425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the free plasma fraction of drugs].
    Bruguerolle B; Jadot G; Valli M; Bouyard L; Zemmour C; Mouchet J; Bouyard P
    Therapie; 1980; 35(4):554-5. PubMed ID: 7466736
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proposal of an analytical pathway for the treatment of poisonings--6--application of blood concentration to the evaluation of toxicity (2): tools for diagnosis and therapy].
    Fukumoto M
    Chudoku Kenkyu; 2006 Oct; 19(4):413-6. PubMed ID: 17133985
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fatal doses and concentrations of drugs in biological objects].
    Fartushnyĭ AF
    Sud Med Ekspert; 1999; 44(5):16-9. PubMed ID: 10616311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.